Zena Salih

485 total citations
20 papers, 309 citations indexed

About

Zena Salih is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Zena Salih has authored 20 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Zena Salih's work include BRCA gene mutations in cancer (6 papers), PARP inhibition in cancer therapy (5 papers) and CAR-T cell therapy research (3 papers). Zena Salih is often cited by papers focused on BRCA gene mutations in cancer (6 papers), PARP inhibition in cancer therapy (5 papers) and CAR-T cell therapy research (3 papers). Zena Salih collaborates with scholars based in United Kingdom, Italy and Austria. Zena Salih's co-authors include Sacha J. Howell, John Weightman, Avinash Gupta, D. Gareth Evans, Antonia Banyard, Richard Marais, Elena Galvani, Paul Lorigan, Sara Valpione and Sarah Mills and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and Nutrients.

In The Last Decade

Zena Salih

20 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zena Salih United Kingdom 7 178 107 54 41 39 20 309
Fani Kalala Greece 9 91 0.5× 182 1.7× 77 1.4× 30 0.7× 47 1.2× 28 355
Judith Kinley United States 6 141 0.8× 40 0.4× 72 1.3× 27 0.7× 15 0.4× 7 291
Ireneusz Dziuba Poland 9 70 0.4× 66 0.6× 80 1.5× 60 1.5× 45 1.2× 17 260
Jaroslav Žák United States 10 129 0.7× 174 1.6× 123 2.3× 112 2.7× 28 0.7× 17 446
Giuseppe Cipollone Italy 7 220 1.2× 287 2.7× 57 1.1× 68 1.7× 22 0.6× 15 404
Hirotoshi Kawashima Japan 8 76 0.4× 157 1.5× 56 1.0× 32 0.8× 21 0.5× 16 304
Maria Antonella Laginestra Italy 12 144 0.8× 82 0.8× 147 2.7× 38 0.9× 104 2.7× 25 382
Anna Laura Putignano Italy 11 96 0.5× 45 0.4× 130 2.4× 47 1.1× 32 0.8× 17 316
Jasper F. Nies Germany 6 118 0.7× 121 1.1× 110 2.0× 31 0.8× 12 0.3× 11 309
Kayo Tanita Japan 11 219 1.2× 150 1.4× 76 1.4× 29 0.7× 19 0.5× 34 395

Countries citing papers authored by Zena Salih

Since Specialization
Citations

This map shows the geographic impact of Zena Salih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zena Salih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zena Salih more than expected).

Fields of papers citing papers by Zena Salih

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zena Salih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zena Salih. The network helps show where Zena Salih may publish in the future.

Co-authorship network of co-authors of Zena Salih

This figure shows the co-authorship network connecting the top 25 collaborators of Zena Salih. A scholar is included among the top collaborators of Zena Salih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zena Salih. Zena Salih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgan, Robert D., Xin Wang, Jurjees Hasan, et al.. (2024). Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer. British Journal of Cancer. 131(12). 1919–1927. 5 indexed citations
2.
Morgan, Robert D., George J. Burghel, Hélene Schlecht, et al.. (2024). Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene. Genetics in Medicine. 26(10). 101230–101230. 5 indexed citations
3.
Morgan, Robert D., George J. Burghel, Michael Bulman, et al.. (2023). Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?. Cancers. 15(3). 730–730. 2 indexed citations
4.
Morgan, Robert D., George J. Burghel, Hélene Schlecht, et al.. (2023). Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer. Cancers. 16(1). 177–177. 2 indexed citations
5.
Valpione, Sara, L Campana, John Weightman, et al.. (2022). Tumour infiltrating B cells discriminate checkpoint blockade-induced responses. European Journal of Cancer. 177. 164–174. 6 indexed citations
6.
Morgan, Robert D., George J. Burghel, Michael Bulman, et al.. (2022). Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer. Journal of Clinical Pathology. 76(10). 684–689. 3 indexed citations
7.
Kopczynska, Maja, Antje Teubner, Arun Abraham, et al.. (2022). Home Parenteral Nutrition in Patients with Advanced Cancer: Quality Outcomes from a Centralized Model of Care Delivery. Nutrients. 14(16). 3379–3379. 6 indexed citations
8.
Morgan, Robert D., George J. Burghel, Michael Bulman, et al.. (2022). BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?. British Journal of Cancer. 127(1). 163–167. 4 indexed citations
9.
Salih, Zena, Antonia Banyard, Elena Galvani, et al.. (2021). T cell immune awakening in response to immunotherapy is age-dependent. European Journal of Cancer. 162. 11–21. 8 indexed citations
10.
Valpione, Sara, Elena Galvani, Piyushkumar A. Mundra, et al.. (2020). Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy. Nature Cancer. 1(2). 210–221. 144 indexed citations
11.
Adderley, Helen, Claire Kelly, Zena Salih, et al.. (2020). Permanent Hair Loss Associated with Taxane Chemotherapy Use in Breast Cancer: a Retrospective Review at Two Tertiary UK Cancer Centres. Clinical Oncology. 32(8). e167–e167. 1 indexed citations
12.
Adderley, Helen, Anne Armstrong, Matthew Harries, et al.. (2020). Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres. European Journal of Cancer Care. 30(3). e13395–e13395. 28 indexed citations
13.
Owen, Laura, Phillip J. Monaghan, Anne Armstrong, et al.. (2019). Oestradiol measurement during fulvestrant treatment for breast cancer. British Journal of Cancer. 120(4). 404–406. 16 indexed citations
14.
Howell, Sacha J., et al.. (2017). Increased risk of breast cancer in neurofibromatosis type 1: current insights. Breast Cancer Targets and Therapy. Volume 9. 531–536. 35 indexed citations
15.
16.
Paglialunga, Luca, Zena Salih, Biagio Ricciuti, & Raffaele Califano. (2016). Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?. ESMO Open. 1(4). e000022–e000022. 14 indexed citations
17.
18.
Mansfield, James, Zena Salih, Lia P. Menasce, et al.. (2015). Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3+ Tregs in follicular lymphoma. British Journal of Cancer. 113(8). 1197–1205. 14 indexed citations
19.
Morris, Gwilym M., Zena Salih, Gareth Wynn, et al.. (2014). Patient radiation dose during fluoroscopically guided biventricular device implantation. Acta cardiologica. Supplementum. 69(5). 491–495. 4 indexed citations
20.
Salih, Zena, Jim Cavet, Mike Dennis, et al.. (2013). Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies. SHILAP Revista de lepidopterología. 2(4). 220–224. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fani Kalala Breakdown of academic impact, for papers by Judith Kinley Breakdown of academic impact, for papers by Ireneusz Dziuba Breakdown of academic impact, for papers by Jaroslav Žák Breakdown of academic impact, for papers by Giuseppe Cipollone Breakdown of academic impact, for papers by Hirotoshi Kawashima Breakdown of academic impact, for papers by Maria Antonella Laginestra Breakdown of academic impact, for papers by Anna Laura Putignano Breakdown of academic impact, for papers by Jasper F. Nies Breakdown of academic impact, for papers by Kayo Tanita
Rankless by CCL
2026